Description of \u3cem\u3eLeucaena\u3c/em\u3e On-Offer Browse at Different \u3cem\u3eLeucaena\u3c/em\u3e Density

Leucaena (Lecuaena lecucephala (Lam.) de Wit) is a tree legume widely used to establish silvopastoral systems along with different tropical grasses. The relation of Leucaena density to browse available at the start of each grazing period in a rotational grazing management is important information when designing a silvopastoral pasture (Anguiano et al., 2013). Then the objective of the study was to determine Leucaena on-offer browse at different Leucaena density

EVALUACIÓN DE USABILIDAD Y EXPERIENCIA DE USUARIO EN SITIOS WEB: CASO DE ESTUDIO EXAVER (USABILITY AND USER EXPERIENCE ASSESSMENT ON WEB SITES: EXAVER CASE STUDY)

Resumen La evaluación de usabilidad juega un papel importante en cada etapa del proceso de diseño de software ya que permite identificar problemas y situaciones que deben ser solucionadas con el objetivo de ofrecer a los usuarios un producto útil que satisfaga sus necesidades. En el caso del diseño de sitios web es recomendable realizar evaluaciones periódicas dentro de un proceso iterativo con la finalidad de evaluar rápidamente diferentes propuestas de diseño, para que, al concluir el proceso, se tenga como resultado un sitio web de fácil uso. El presente trabajo describe el proceso de aplicación de dos pruebas de usabilidad a la página web del examen de certificación de lengua inglesa de la Universidad Veracruzana, denominado EXAVER. A partir del análisis de los resultados de las pruebas se identifican aspectos de usabilidad a mejorar del sitio web actual. Palabra(s) Clave: evaluación de usabilidad, experiencia de usuario, usabilidad web. Abstract Usability evaluation plays an important role in each stage of the software design process since it allows to identify problems and situations that must be solved to offer users a useful product that meets their needs. In the case of web-site design, it is advisable to carry out periodic evaluations within an iterative process where different design proposals are quickly evaluated to achieve an easy and friendly use website. This paper describes the process of applying two usability tests on the website of the English language certification exam of the Universidad Veracruzana, called EXAVER. From the analysis of the test results, aspects of usability to be improved on the current website are identified. Keywords: usability evaluation, user experience, web usability

Virucidal and Synergistic Activity of Polyphenol-Rich Extracts of Seaweeds against Measles Virus

Although preventable by vaccination, Measles still causes thousands of deaths among young children worldwide. The discovery of new antivirals is a good approach to control new outbreaks that cause such death. In this study, we tested the antiviral activity against Measles virus (MeV) of Polyphenol-rich extracts (PPs) coming from five seaweeds collected and cultivated in Mexico. An MTT assay was performed to determine cytotoxicity effect, and antiviral activity was measured by syncytia reduction assay and confirmed by qPCR. PPs from Ecklonia arborea (formerly Eisenia arborea, Phaeophyceae) and Solieria filiformis (Rhodophyta) showed the highest Selectivity Index (SI), \u3e3750 and \u3e576.9 respectively. Both PPs extracts were selected to the subsequent experiments owing to their high efficacy and low cytotoxicity compared with ribavirin (SI of 11.57). The combinational effect of PPs with sulphated polysaccharides (SPs) and ribavirin were calculated by using Compusyn software. Synergistic activity was observed by combining both PPs with low concentrations of Solieria filiformis SPs (0.01 µg/mL). The antiviral activity of the best combinations was confirmed by qPCR. Virucidal assay, time of addition, and viral penetration evaluations suggested that PPs act mainly by inactivating the viral particle. To our knowledge, this is the first report of the virucidal effect of Polyphenol-rich extracts of seaweeds

PATOGENICIDAD Y VIRULENCIA DE CEPAS DE BACILLUS THURINGIENSIS NATIVAS DEL ESTADO DE MORELOS SOBRE DIATRAEA MAGNIFACTELLA (LEPIDOPTERA: CRAMBIDAE)

Sugarcane is one of the most important industrial crops in Mexico, several insects feed on it, causing important economic losses. At the state of Morelos two species are found; Diatraea magnifactella and Eoreuma loftini. To control these borers chemical insecticides are used, today there are not any bioinsecticide based on entomopathogenic bacteria. It has already been reported in the literature against other borer species the use of entomopathogenic bacteria, so in this work was proposed to isolate Bacillus thuringiensis (Bt) from cadavers of D. magnifactella to evaluate the pathogenicity and virulence of bacterial isolates on neonate larva. It was possible the establishment a colony of D. magnifactella at laboratory, ensuring the health of the larvae used in bioassays. We obtained a total of 118 bacterial isolates, presumably from B. thuringiensis. Which were grouped into three groups, depending on thier protein profile. Six of the 118 strains caused more than 50% of mortality in neonate larvae of D. magnifactella. The LC50 of isolates been defined, the best was the B148 by 254.01 ng/cm2 of food. The LC50 the commercial strain HD1 was 417.61 ng/cm2, used as appositive control. The five remaining isolates showed LC50 greater than that of the positive control.La caña de azúcar representa uno de los cultivos industriales más importantes en México, diversos insectos se alimentan de ésta, provocando pérdidas económicas considerables. Para el estado de Morelos se reporta la presencia de los barrenadores Diatraea magnifactella y Eoreuma loftini. Para su control se han usado insecticidas químicos, a la fecha no existen bioinsecticidas a base de bacterias entomopatógenas. Existen reportes de evaluaciones in vitro y en campo contra otras especies de barrenadores, por lo que en el presente trabajo se aislaron cepas de Bacillus thuringiensis (Bt) a partir de cadáveres de D. magnifactella. Se evaluó la patogenicidad y virulencia de las cepas bacterianas sobre larvas neonatas del barrenador para lo cual se estableció un pie de cría de D. magnifactella en laboratorio, garantizando así la sanidad de las larvas usadas en los bioensayos. Se obtuvo un total de 118 cepas de B. thuringiensis. Los cuales se agruparon en tres categorías, dependiendo del peso molecular de las proteínas mayoritarias (perfil proteico) producidas por la bacteria. De los bioensayos de patogenicidad realizados, seis de las 118 cepas evaluadas fueron las que ocasionaron una mortalidad mayor al 50% en las larvas neonatas de D. magnifactella. Se determinó la Concentración Letal 50 de éstas seis cepas, la que presentó mejores resultados fue la cepa B148 con CL50 de 254.01 ng/cm2 de dieta, menor a la de la cepa comercial HD1 417.61 ng/cm2, evaluada como testigo positivo. Las cinco cepas restantes presentaron CL50 superiores a la de la cepa testigo

Vía aérea pequeña: de la definición al tratamiento

La vía aérea pequeña, presente desde los orígenes de la humanidad y descrita hace apenas un siglo, se ha descubierto recientemente como el sitio anatómico donde inicia la inflamación provocada por algunas enfermedades pulmonares obstructivas: asma y enfermedad pulmonar obstructiva crónica (EPOC), per se. Se ha identificado disfunción de la vía aérea pequeña en el 91% de los pacientes asmáticos y en una gran proporción de quienes padecen EPOC. En los pacientes sin enfermedad, la vía aérea pequeña representa el 98.8% (4500 mL) del volumen pulmonar total, y solo aporta del 10 al 25% de la resistencia pulmonar total; sin embargo, en sujetos con obstrucción puede suponer el 90% de la resistencia total. A pesar de esto, sus características morfológicas y funcionales permiten que la disfunción pase inadvertida por métodos diagnósticos convencionales, por ejemplo la espirometría. Con base en lo anterior, el objetivo de este estudio fue revisar el panorama general de los métodos disponibles para evaluar la vía aérea pequeña y los posibles tratamientos asociados con esta zona silente. Palabras clave: Vía aérea pequeña; resistencia al flujo aéreo; asma; EPOC

Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism

© The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.Whole-brain radiotherapy (WBRT) is the treatment backbone for many patients with brain metastasis; however, its efficacy in preventing disease progression and the associated toxicity have questioned the clinical impact of this approach and emphasized the need for alternative treatments. Given the limited therapeutic options available for these patients and the poor understanding of the molecular mechanisms underlying the resistance of metastatic lesions to WBRT, we sought to uncover actionable targets and biomarkers that could help to refine patient selection. Through an unbiased analysis of experimental in vivo models of brain metastasis resistant to WBRT, we identified activation of the S100A9-RAGE-NF-κB-JunB pathway in brain metastases as a potential mediator of resistance in this organ. Targeting this pathway genetically or pharmacologically was sufficient to revert the WBRT resistance and increase therapeutic benefits in vivo at lower doses of radiation. In patients with primary melanoma, lung or breast adenocarcinoma developing brain metastasis, endogenous S100A9 levels in brain lesions correlated with clinical response to WBRT and underscored the potential of S100A9 levels in the blood as a noninvasive biomarker. Collectively, we provide a molecular framework to personalize WBRT and improve its efficacy through combination with a radiosensitizer that balances therapeutic benefit and toxicity.info:eu-repo/semantics/publishedVersio

Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications

BackgroundIn Mexico, the incidence of acute myeloid leukemia (AML) has increased in the last few years. Mortality is higher than in developed countries, even though the same chemotherapy protocols are used. CCAAT Enhancer Binding Protein Alpha (CEBPA) mutations are recurrent in AML, influence prognosis, and help to define treatment strategies. CEBPA mutational profiles and their clinical implications have not been evaluated in Mexican pediatric AML patients.Aim of the StudyTo identify the mutational landscape of the CEBPA gene in pediatric patients with de novo AML and assess its influence on clinical features and overall survival (OS).Materials and MethodsDNA was extracted from bone marrow aspirates at diagnosis. Targeted massive parallel sequencing of CEBPA was performed in 80 patients.ResultsCEBPA was mutated in 12.5% (10/80) of patients. Frameshifts at the N-terminal region were the most common mutations 57.14% (8/14). CEBPA biallelic (CEBPABI) mutations were identified in five patients. M2 subtype was the most common in CEBPA positive patients (CEBPAPOS) (p = 0.009); 50% of the CEBPAPOS patients had a WBC count > 100,000 at diagnosis (p = 0.004). OS > 1 year was significantly better in CEBPA negative (CEBPANEG) patients (p = 0.0001). CEBPAPOS patients (either bi- or monoallelic) had a significantly lower OS (p = 0.002). Concurrent mutations in FLT3, CSF3R, and WT1 genes were found in CEBPAPOS individuals. Their contribution to poor OS cannot be ruled out.ConclusionCEBPA mutational profiles in Mexican pediatric AML patients and their clinical implications were evaluated for the first time. The frequency of CEBPAPOS was in the range reported for pediatric AML (4.5–15%). CEBPA mutations showed a negative impact on OS as opposed to the results of other studies

Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy

The main objective of the National Project for Research and Incidence of Childhood Leukemias is to reduce early mortality rates for these neoplasms in the vulnerable regions of Mexico. This project was conducted in the states of Oaxaca, Puebla, and Tlaxcala. A key strategy of the project is the implementation of an effective roadmap to ensure that leukemia patients are the target of maximum benefit of interdisciplinary collaboration between researchers, clinicians, surveyors, and laboratories. This strategy guarantees the comprehensive management of diagnosis and follow-up samples of pediatric patients with leukemia, centralizing, managing, and analyzing the information collected. Additionally, it allows for a precise diagnosis and monitoring of the disease through immunophenotype and measurable residual disease (MRD) studies, enhancing research and supporting informed clinical decisions for the first time in these regions through a population-based study. This initiative has significantly improved the diagnostic capacity of leukemia in girls, boys, and adolescents in the regions of Oaxaca, Puebla, and Tlaxcala, providing comprehensive, high-quality care with full coverage in the region. Likewise, it has strengthened collaboration between health institutions, researchers, and professionals in the sector, which contributes to reducing the impact of the disease on the community